Top compounds associated with response to LRRC66


Feature Type Standardized
Nominal ANOVA
mRNA ABT-888 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA niclosamide CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA YM-155 GDSC1000 pan-cancer AAC -0.14 4e-05
mRNA austocystin d CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA 17-AAG CCLE pan-cancer AAC 0.18 0.0002
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV